front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |review |
NSCLC can differentiate into:
Squamous cell lung cancer Non-squamous cell tumors without neuroendocrine features (80%); Non-squamous cell tumors with neuroendocrine cell features (20%). The recogntion of neuroendocrine features within this subgroup is important in that this group NE-NSCLC (neuroendocrine non-small cell lung cancer) should probably be treated with post-operative adjuvant chemotherapy. |